公司資料
PLUS THERAPEUTICS, Inc. 股價、新聞與催化劑
- 股票代碼:
- PSTV
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
3.87 USD (+6.03%)
收盤價
最後更新: 2026年7月31日
37.7M USD
市值
股價為何變動
目前無法取得 PSTV 的收盤價變動背景。
公司概覽
業務概覽
PLUS Therapeutics is an oncology company focused on radiotherapeutics and targeted treatment delivery for cancer. Its story is built around the use of radiation-based approaches to address hard-to-treat tumors.
所在地與產業分類
PLUS Therapeutics is headquartered in the United States and listed on NASDAQ. It sits in small-cap oncology biotechnology.
商業模式特徵
The company depends on clinical progress, regulatory steps, and the ability to prove its delivery strategy can improve cancer outcomes. Investors usually track readouts, manufacturing, and financing.
生技產業定位
PLUS Therapeutics occupies a niche radiotherapy position within biotech. The stock is catalyst-sensitive because its value depends on narrow oncology programs and execution.
未來催化劑
- PLUS Therapeutics’s catalysts are Rhenium-based oncology programs and any clinical or regulatory update that keeps the platform moving. The company remains highly dependent on proof of concept.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。